Business Segments Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.83 USD | +2.07% |
|
-0.62% | -6.27% |
Feb. 05 | Myriad Genetics Get 2 Patents for Molecular Residual Disease Assay | MT |
Feb. 05 | Myriad Genetics Announces Two New Patents Granted For Its Molecular Residual Disease (MRD) Assay | RE |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology | - | - | 691M | 678M | 753M | |||||
Total Assets | - | - | 1.32B | 1.2B | 1.15B | |||||
Interest Expense | - | - | -6.6M | -3.2M | -2.9M | |||||
Income Tax Expense | - | - | -29.9M | -28.6M | 1.1M | |||||
CAPEX | - | - | -18M | -45.3M | -63.2M | |||||
EBT | - | - | -57.1M | -141M | -262M | |||||
D&A | - | - | 62.8M | 52.7M | 61.9M | |||||
Operating Income | - | - | -190M | -141M | -257M | |||||
Net Income | - | - | -27.2M | -112M | -263M | |||||
Other | 61.7M | 56.2M | - | - | - | |||||
Total Assets | 155M | 253M | - | - | - | |||||
D&A | 5.3M | 4.6M | - | - | - | |||||
Operating Income | -126M | -173M | - | - | - | |||||
Life Sciences Tools and Services | ||||||||||
Companion Diagnostics | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Diagnostics | 789M | 543M | - | - | - | |||||
Total Assets | 1.22B | 994M | - | - | - | |||||
D&A | 67.7M | 67M | - | - | - | |||||
Operating Income | 133M | -2.8M | - | - | - | |||||
Total Assets | 192M | 172M | - | - | - | |||||
Gene Research and Development | ||||||||||
Total Assets | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
United States | 789M | 551M | 604M | 592M | 118M | |||||
Total Assets | 1.27B | 1.19B | 871M | 983M | 962M | |||||
Rest of world | - | 48.8M | 86.9M | 86.9M | 1.3M | |||||
Total Assets | 105M | 56.8M | 51.1M | 45.6M | 44M | |||||
Total Assets | 192M | - | - | - | - | |||||
Total Assets | - | 172M | 399M | 170M | 141M |
- Stock Market
- Equities
- MYGN Stock
- Financials Myriad Genetics, Inc.
- Business Segments